151 |
Gilead Sciences, Inc. et al v. Mylan Inc. et al |
1:14-cv-03928 |
S.D.N.Y. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
152 |
Gilead Sciences, Inc. et al v. Mylan Inc. et al |
1:14-cv-03928 |
S.D.N.Y. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
153 |
AbbVie Inc. v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-01236 |
D.Del. |
|
|
|
|
154 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
155 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
156 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
157 |
Boehringer Ingelheim Pharma Gmbh & Co. KG et al v. Mylan Pharmaceuticals Inc. |
1:14-cv-00146 |
N.D.W.Va. |
|
|
|
|
158 |
Boehringer Ingelheim Pharma Gmbh & Co. KG et al v. Mylan Pharmaceuticals Inc. |
1:14-cv-00146 |
N.D.W.Va. |
|
|
|
|
159 |
Boehringer Ingelheim Pharma Gmbh & Co. KG et al v. Mylan Pharmaceuticals Inc. |
1:14-cv-00146 |
N.D.W.Va. |
|
|
|
|
160 |
Boehringer Ingelheim Pharma Gmbh & Co. KG et al v. Mylan Pharmaceuticals Inc. |
1:14-cv-00146 |
N.D.W.Va. |
|
|
|
|
161 |
Acorda Therapeutics, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-00139 |
N.D.W.Va. |
|
|
|
|
162 |
Acorda Therapeutics, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-00139 |
N.D.W.Va. |
|
|
|
|
163 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:14-cv-00099 |
N.D.W.Va. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
164 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:14-cv-00099 |
N.D.W.Va. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
165 |
AstraZeneca AB v. Mylan Pharmaceuticals Inc. |
1:14-cv-00094 |
N.D.W.Va. |
|
|
|
|
166 |
Roche Palo Alto LLC et al v. Mylan Pharmaceuticals Inc. |
1:13-cv-01532 |
D.Del. |
|
|
|
|
167 |
Roche Palo Alto LLC et al v. Mylan Pharmaceuticals Inc. |
1:13-cv-01532 |
D.Del. |
|
|
|
|
168 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
169 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
170 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
171 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
172 |
Santarus Inc. et al v. Mylan Inc. et al |
1:13-cv-00145 |
D.Del. |
|
|
|
|
173 |
Santarus Inc. et al v. Mylan Inc. et al |
1:13-cv-00145 |
D.Del. |
|
|
|
|
174 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
175 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
176 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
177 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
178 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
179 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
180 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
181 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
182 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
183 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
184 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
185 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
186 |
Pfizer Inc. v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00269 |
D.Del. |
|
|
|
|
187 |
Endo Pharmaceuticals Inc. v. Mylan Technologies Inc. et al |
1:11-cv-00220 |
D.Del. |
|
|
|
|
188 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
189 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
190 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
191 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
192 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
193 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
194 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
195 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
196 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
197 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
198 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
199 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
200 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|